EFDID: 457596EFD: View Filing

Issuer: MyMD Pharmaceuticals, Inc. (0001321834) - D

Accession: 0001493152-22-024345 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001321834
  • Entity Name:
    MyMD Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    NEW JERSEY
  • Year of Inc:
    Over 5 years ago
  • Address:
    855 N. WOLFE STREET
    SUITE 601
    BALTIMORE, MD 21205
  • Persons:
    Related Persons 9
    Chris Chapman
    Executive Officer, Director 
    Director, President and Chief Medical Officer
    Adam Kaplin
    Executive Officer 
    Chief Scientific Officer
    Paul Rivard
    Executive Officer 
    Executive Vice President of Operations and General Counsel
    Ian Rhodes
    Executive Officer 
    Interim Chief Financial Officer
    Craig Eagle
    Director
    Christopher Schreiber
    Director
    Joshua Silverman
    Director 
    Chairman of the Board
    Jude Uzonwanne
    Director
    Bill White
    Director
EDGAR: Offering Information
  • Accession Date:
    08/30/2022
  • First Sale Date:
    08/15/2022
  • Offering Amount:
    $7,411,761
  • Amount Sold:
    $0
  • Amount Remaining:
    $7,411,761
  • Exemptions:
    Rule 506
  • Security Type(s):
  • Sales Clarification:
    Represents warrants to purchase up to 1,411,764 shares of common stock at $5.25/share.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CT, NY
Inactive:IL
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Dawson James Securities, Inc. 130645 None None CT, FL, IL, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
MyMD Pharmaceuticals, Inc./s/ Chris ChapmanChris ChapmanPresident, Chief Medical Officer, and Director2022-08-30